370-P: Anxiety and Depressive Symptoms of Type 1 Diabetes and Severe Hypoglycemia in Adult Continuous Glucose Monitor Users

Introduction 0.001); however, correlation coefficients were small. There was no significant relationship between anxiety/depression and IAH (p range=0.10-0.71). The problematic SHE cohort had higher reported anxiety/depression means (Table). Conclusion: Although higher SHE frequency was associated with a small increase of anxiety/depressive symptoms, IAH alone was not. Findings highlight the need to better understand the complex relationship between SHE and IAH in the experience of anxiety/depression in adults with T1D. Disclosure A. Boateng-Kuffour: Employee; Vertex Pharmaceuticals Incorporated. P. Callahan: Employee; Vertex Pharmaceuticals Incorporated. K. Chandarana: Employee; Vertex Pharmaceuticals Incorporated. Stock/Shareholder; Vertex Pharmaceuticals Incorporated, Novo Nordisk, Eli Lilly and Company. T. Gupta: Employee; Vertex Pharmaceuticals Incorporated. L. Chen: None. C.S. Kelly: None. H. Nguyen: None. K.S.M. Chapman: None. E.M. Cornelius: None. W. Wolf: None. W.H. Polonsky: Research Support; Abbott Diagnostics, Dexcom, Inc. Consultant; Eli Lilly and Company, Sanofi. Advisory Panel; embecta. Consultant; Vertex Pharmaceuticals Incorporated. Advisory Panel; 9am Health. Funding Vertex Pharmaceuticals Incorporated